Baudot Amandine, Oriol Mathieu, Tinquaut Fabien, Moine Valentin, Moriceau Guillaume, Muron Thierry, Pacaut Cécile, Collard Olivier, Jacquin Jean-Philippe, Saban-Roche Léa, Bosacki Claire, Regnier-Denois Véronique, Chauvin Franck, Bourmaud Aurélie
Centre Hygée, institut de cancérologie Lucien-Neuwirth, 108 bis, avenue A.-Raimond, 42270 Saint-Priest-en-Jarez, France; CIC-EC, Inserm 1408, 42000 Saint-Étienne, France.
Centre Hygée, institut de cancérologie Lucien-Neuwirth, 108 bis, avenue A.-Raimond, 42270 Saint-Priest-en-Jarez, France; CIC-EC, Inserm 1408, 42000 Saint-Étienne, France; Faculté de médecine Jacques-Lisfranc, 42000 Saint-Étienne, France.
Bull Cancer. 2016 Mar;103(3):241-51. doi: 10.1016/j.bulcan.2016.01.010. Epub 2016 Feb 23.
There is a plea for the development of tools allowing the screening of fragile patients under oral chemotherapy. Such tools would identify patients with difficulties for being adherent or for having low side effects management skills. The aim of this study is to validate psychometric characteristics of a questionnaire assessing patients' adherence and skill level of management for oral capecitabine treatment.
Questionnaire's psychometric validation study. Prospective monocentric cohort. Cases-simulated questionnaire was constructed, according to recommendations, from the results of a socio-anthropological study. Validation phases included: a pre-testing and a field-testing including acceptability, scale reliability and internal consistency were conducted involving experts and patients sample.
Pre-testing excluded 1 item. Acceptability phase included 15 patients, who did not change any of the questions. Reliability and internal consistency were tested with 67 patients. Cancer site did not statistically influence questionnaire answers. No correlation was identify with the analyse performed for the internal consistency testing.
This questionnaire has shown to be a valid tool for the assessment of the adherence and side effect management skill for patients with capecitabine treatment. It can easily be uses as a screening tool for prescribers. It can also be used as an evaluation tool for a therapeutic education programme in this field.
人们呼吁开发能够筛查接受口服化疗的脆弱患者的工具。此类工具将识别出在坚持治疗或副作用管理技能较低方面存在困难的患者。本研究的目的是验证一份评估患者对口服卡培他滨治疗的依从性和管理技能水平的问卷的心理测量学特征。
问卷的心理测量学验证研究。前瞻性单中心队列研究。根据一项社会人类学研究的结果,按照建议构建了病例模拟问卷。验证阶段包括:进行预测试和现场测试,涉及专家和患者样本,测试内容包括可接受性、量表信度和内部一致性。
预测试排除了1个项目。可接受性阶段纳入了15名患者,他们未对任何问题进行修改。对67名患者进行了信度和内部一致性测试。癌症部位对问卷答案无统计学影响。在进行内部一致性测试的分析中未发现相关性。
这份问卷已被证明是评估卡培他滨治疗患者依从性和副作用管理技能的有效工具。它可以很容易地用作开处方者的筛查工具。它也可以用作该领域治疗教育项目的评估工具。